- Country: Germany
- Summary: Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Albendazole, Atc P02ca03 (Obg) for the Period August 1St, 2024 - July 31St, 2026
- DET Ref No: 102813149
- Deadline: 05 Jun 2026
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: 1.00
- Notice Type: Tender
- Document Ref. No.:Login to see details
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details.
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINConclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Albendazole, Atc P02ca03 (Obg) for the Period August 1St, 2024 - July 31St, 2026 - Germany Tender
The DAK HEALTH, a Government sector organization in Germany, has announced a new tender for Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Albendazole, Atc P02ca03 (Obg) for the Period August 1St, 2024 - July 31St, 2026. This tender is published on GermanyTenders under DET Ref No: 102813149 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2026-06-05.
The estimated tender value is 1.00, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
